Paracoccidioidomycosis: Latin America's own fungal disorder

Current Fungal Infection Reports

Volumn 6, Issue 4, 2012, Pages 303-311

  Restrepo, Angela ^a   Gómez, Beatriz L ^a,b   Tobón, Angela ^a  

^a Unidad de Biología Celular y Molecular   (Colombia)

^b UNIVERSIDAD DEL ROSARIO   (Colombia)

Author keywords

Acute subacute paracoccidioidomycosis; Chronic; Endemic areas; Laboratory diagnosis; Latency; Management; Paracoccidioides brasiliensis; Paracoccidioidomycosis; South American Blastomycosis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CORTICOSTEROID; COTRIMOXAZOLE; FLUCONAZOLE; FUNGUS ANTIGEN; ITRACONAZOLE; KETOCONAZOLE; PYRROLE DERIVATIVE; RIBOSOME RNA; SULFONAMIDE; VORICONAZOLE;

AGRICULTURE; ALCOHOLISM; ANTIGEN RECOGNITION; ARTICLE; BRAZIL; CAUSE OF DEATH; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPLEMENT FIXATION TEST; CONIDIUM; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DOT HYBRIDIZATION; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; ENVIRONMENTAL TEMPERATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FUNGAL GENE; FUNGUS CULTURE; FUNGUS IDENTIFICATION; HISTOPATHOLOGY; HUMAN; IMMUNODIFFUSION; INCIDENCE; LOOP MEDIATED ISOTHERMAL AMPLIFICATION; LOWER RESPIRATORY TRACT INFECTION; LUNG FIBROSIS; MOLECULAR DIAGNOSIS; NONHUMAN; NUTRITION; OCCUPATIONAL EXPOSURE; PARACOCCIDIOIDES BRASILIENSIS; PNEUMONIA; QUALITY OF LIFE; RACE; REAL TIME POLYMERASE CHAIN REACTION; RECURRENT INFECTION; RNA GENE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SEX DIFFERENCE; SMOKING; SOUTH AMERICAN BLASTOMYCOSIS; SURVIVAL; UNSPECIFIED SIDE EFFECT; WESTERN BLOTTING;

EID: 84884140711     PISSN: 19363761     EISSN: 1936377X     Source Type: Journal    
DOI: 10.1007/s12281-012-0114-x     Document Type: Article

References (91)

1. Lacaz C, Porto E, Martins J, et al. Paracoccidioidomicose. In: Lacaz C, Porto E, Martins J, et al., editors. Tratado de micologia médica lacaz. 9th ed. Sao Paulo: Sarvier; 2002. p. 639-729.
2. Wanke B, Aidê MA. Chapter 6 - paracoccidioidomycosis. J Bras Pneumol. 2009;35:1245-9.
3. Ameen M, Talhari C, Talhari S. Advances in paracoccidioidomycosis. Clin Exp Dermatol. 2010;35:576-80.
4. Restrepo A, Tobon AM. Paracoccidioides brasiliensis. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas and Bennett's principles and practice of infectious diseases. 7th ed. Philadelphia: Elsevier; 2010. p. 3357-63.
5. • Restrepo A, Gónzalez A, Agudelo CA. Paracoccidioidomycosis. In: Dismukes W, Kauffman C, Pappas P, Sobel J, editors. Essentials of medical mycology. 2nd ed. New York: Springer; 2011. p. 367-85. This chapter is a comprehensive record of the mycosis, its etiologic agent, the host-fungus interaction and treatment approach. Adequate for "starters".
6. • Cano LE, González A, Lopera D, et al. Pulmonary paracoccidioidomycosis: clinical, immunological and histopathological aspects. In: Malcolm-Irusen E, editor. Lung diseases: selected state of the art reviews. Rijeka: InTech; 2012. p. 359-92. An updated review dealing specially with the host-fungus tissue interactions in an animal model that focuses in detailed tissue changes as a result of the fungus invasive capacities.
7. Yamaga LY, Benard G, Hironaka FH, et al. The role of gallium-67 scan in defining the extent of disease in an endemic deep mycosis, paracoccidioidomycosis: a predominantly multifocal disease. Eur J Nucl Med Mol Imaging. 2003;30:888-94.
8. Restrepo A, McEwen JG, Castaneda E. The habitat of Paracoccidioides brasiliensis: how far from solving the riddle? Med Mycol. 2001;39:233-41.
9. Laccourreye O, Mirghani H, Brasnu D, et al. Imported acute and isolated glottic paracoccidioidomycosis. Ann Otol Rhinol Laryngol. 2010;119:89-92.
10. Ramírez-Olivencia G, Ramírez-Rubio O, González PR, et al. Paracoccidioidomycosis in a Spanish missionary. J Travel Med. 2010;17:139-40.
11. Botas-Velasco M, Jover-Díaz F, Ortiz de la Tabla-Duccase V, et al. Imported paracoccidioidomycosis in Spain. Enferm Infecc Microbiol Clin. 2010;28:259-60.
12. Onda H, Komine M, Murata S, et al. Letter: imported paracoccidioidomycosis in Japan. Dermatol Online J. 2011;17:11.
13. • Buitrago MJ, Bernal-Martínez L, Castelli MV, et al. Histoplasmosis and paracoccidioidomycosis in a non-endemic area: a review of cases and diagnosis. J Travel Med. 2011;18:26-33. An interesting and well-planned review of two "foreign" mycoses diagnosed in non-endemic settings. Of especial interest to European physicians caring for Latin American immigrants.
14. Kurai H, Ohmagari N, Ito K, et al. A case of oral paracoccidioidomycosis suspected to be pharyngeal cancer. Med Mycol J. 2012;53:49-52.
15. Yoshimura Y, Tachikawa N, Ooslawa T, et al. A case of paracoccidioidomycosis with severe adrenal insufficiency. Kansenshogaku Zasshi. 2012;86:291-4.
16. Armas M, Ruivo C, Alves R, et al. Pulmonary paracoccidioidomycosis: a case report with high-resolution computed tomography findings. Rev Port Pneumol. 2012;18:190-3.
17. Borelli D. Some ecological aspects of Paracoccidioidomycosis [Scient Publ. 254]. Presented at the 1st Pan American Symposium. Medellín, Colombia; October 25-27, 1971.
18. Goncalves AJ, Londero AT, Terra GM, et al. Paracoccidioidomycosis in children in the state of Rio de Janeiro (Brazil). Geographic distribution and the study of a "reservarea". Rev Inst Med Trop Sao Paulo. 1998;40:11-3.
19. Fonseca ER, Pardal PP, Severo LC. Paracoccidioidomycosis in children in Belem, Para. Rev Soc Bras Med Trop. 1999;32:31-3.
20. •• Bellissimo-Rodrigues F, Machado AA, Martinez R. Paracoccidioidomycosis: epidemiological features of a 1,000-cases series from a hyperendemic area on the Southeast of Brazil. AmJTrop Med Hyg. 2011;85:546-50. This article analyzes the largest series of paracoccidioidomycosis patients, one thousand, ever analyzed with emphasis on epidemiological and clinical aspects.
21. Arantes TD, Theodoro RC, Da Graça Macoris SA, et al. Detection of Paracoccidioides spp. in environmental aerosol samples. Med Mycol. 2012. doi: 10.3109/13693786.2012.698444.
22. Calle D, Rosero DS, Orozco LC, et al. Paracoccidioidomycosis in Colombia: an ecological study. Epidemiol Infect. 2001;126:309-15.
23. Franco M, Bagagli E, Scapolio S, et al. A critical analysis of isolation of Paracoccidioides brasiliensis from soil. Med Mycol. 2000;38:185-91.
24. • Barrozo LV, Benard G, Silva ME, et al. First description of a cluster of acute/subacute paracoccidioidomycosis cases and its association with a climatic anomaly. PLoS Negl Trop Dis. 2010;4:e643. An important approach when searching for connections among climate, incidence and possible clustering of juvenile patients in a hyperendemic Brazilian area.
25. Bagaggli E, Franco M, Bosco Sde M, et al. High frequency of Paracoccidioides brasiliensis infection in armadillos (Dasypus novemcinctus): an ecological study. Med Mycol. 2003;41:217-23.
26. Ricci G, Mota FT, Wakamatsu A, et al. Canine paracoccidioidomycosis. Med Mycol. 2004;42:379-83.
27. Richini-Pereira VB, Bosco Sde M, Griese J, et al. Molecular detection of Paracoccidioides brasiliensis in road-killed wild animals. Med Mycol. 2008;46:35-40.
28. Oliveira GG, Navarro IT, Freire RL. Serological survey of Paracoccidioidomycosis in sheep. Mycopathologia. 2012;173:63-8.
29. Queiroz-Telles F. Influence of alternating coffee and sugar cane agriculture in the incidence of paracoccidioidomycosis. Proceedings X International Congress on Paracoccidioidomycosis: a centennial celebration. Medellín, Colombia, August 7-10, 2008. p. 129.
30. Paniago AM, Aguiar JI, Aguiar ES, et al. Paracoccidioidomycosis: a clinical and epidemiological study of 422 cases observed in Mato Grosso do Sul. Rev Soc Bras Med Trop. 2003;36:455-9.
31. •• Colombo AL, Tobón A, Restrepo A, et al. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol. 2011;49:785-98. A concise and well organized article on the importance of endemic systemic mycoses in Latin America.
32. • Shankar J, Restrepo A, Clemons KV, et al. Hormones and the resistance of women to paracoccidioidomycosis. Clin Microbiol Rev. 2011;24:296-313. An update on the hormonal influences occurring in this mycosis that also serves to present the disease and its most important epidemiological, clinical and immune-related aspects.
33. Loth EA, Castro SV, Silva JR, et al. Occurrence of 102 cases of paracoccidioidomycosis in 18 months in the Itaipu Lake region, Western Paraná. Rev Soc Bras Med Trop. 2011;44:636-7.
34. Brazão-Silva MT, Andrade MF, Franco T, et al. Paracoccidioidomycosis: a series of 66 patients with oral lesions from an endemic area. Mycoses. 2011;54:e189-95.
35. • Queiroz-Telles F, Escuissato DL. Pulmonary paracoccidioidomycosis. Semin Respir Crit Care Med. 2011;32:764-74. An update on the primary manifestations of the mycosis.
36. • Bellissimo-Rodrigues F, Vitali LH, Martinez R. Serological diagnosis of paracoccidioidomycosis in HIV-coinfected patients. Mem Inst Oswaldo Cruz. 2010;105:904-7. The unexplained paucity of the dual HIV- paracoccidioidomycosis occurrence is approached in this apparently diagnosis-geared paper.
37. Nucci M, Colombo AL, Queiroz-Telles F. Paracoccidioidomycosis. Curr Fungal Infect Rep. 2009;3:15-20.
38. Coutinho ZF, Silva D, Lazera M, et al. Paracoccidioidomycosis mortality in Brazil (1980-1995). Cad Saude Publica. 2002;18:1441-54.
39. Bittencourt JI, de Oliveira RM, Coutinho ZF. Paracoccidioidomycosis mortality in the State of Parana, Brazil, 1980/1998. Cad Saude Publica. 2005;21:1856-64.
40. Santo AH. Paracoccidioidomycosis-related mortality trend, state of Sao Paulo, Brazil: a study using multiple causes of death. Rev Panam Salud Publica. 2008;23:313-24.
41. • Ribeiro LC, Hahn RC, Favalessa OC, et al. Systemic mycosis: factors associated with death among patients infected with the human immunodeficiency virus, Cuiabá, State of Mato Grosso, Brazil, 2005-2008. Rev Soc Bras Med Trop. 2009;42:698-705. A solid analysis on the influence of paracoccidioidomycosis in the death toll of HIV-infected patients.
42. • Prado M, Silva MB, Laurenti R, et al. Mortality due to systemic mycoses as a primary cause of death or in association with AIDS in Brazil: a review from 1996 to 2006. Mem Inst Oswaldo Cruz. 2009;104:513-21. This paper analyzes the importance of the mycosis as the cause of death in this particular patient population.
43. • Martines R. Paracoccidioidomycosis: the dimension of the problem of a neglected disease. Rev Soc Bras Med Trop. 2010;43:480. A solid editorial written by the most experienced paracoccidioidomycosis physician in Brazil who calls the disease a neglected one.
44. San-Blas G, Niño-Vega G, Iturriaga T. Paracoccidioides brasiliensis and paracoccidioidomycosis: molecular approaches to morphogenesis, diagnosis, epidemiology, taxonomy and genetics. Med Mycol. 2002;40:225-42.
45. Cock AM, Cano LE, Vélez D, et al. Fibrotic sequelae in pulmonary paracoccidioidomycosis: histopathological aspects in BALB/c mice infected with viable and non-viable Paracoccidioides brasiliensis propagules. Rev Inst Med Trop Sao Paulo. 2000;42:59-66.
46. Terçarioli GR, Bagagli E, Reis GM, et al. Ecological study of Paracoccidioides brasiliensis in soil: growth ability, conidia production and molecular detection. BMC Microbiol. 2007;7:92.
47. Gomez BL, Nosanchuk JD, Díez S, et al. Detection of melanin-like pigments in the dimorphic fungal pathogen Paracoccidioides brasiliensis in vitro and during infection. Infect Immun. 2001;69:5760-7.
48. Urán ME, Nosanchuk JD, Restrepo A, et al. Detection of antibodies against Paracoccidioides brasiliensis melanin in in vitro and in vivo studies during infection. Clin Vaccine Immunol. 2011;18:1680-8.
49. Silva MB, Thomaz L, Marques AF, et al. Resistance of melanized yeast cells of Paracoccidioides brasiliensis to antimicrobial oxidants and inhibition of phagocytosis using carbohydrates and monoclonal antibody to CD18. Mem Inst Oswaldo Cruz. 2009;104:644-8.
50. Bialek R, Ibrecevic A, Fothergill A, et al. Small subunit ribosomal DNA sequences shows Paracoccidioides brasiliensis closely related to Blastomyces dermatitidis. J Clin Microbiol. 2000;38:3190-3.
51. Matute DR, Sepúlveda VE, Quesada LM, et al. Microsatellite analysis of three phylogenetic species of Paracoccidioides brasiliensis. J Clin Microbiol. 2006;44:2153-7.
52. Teixeira MM, Theodoro RC, de Carvalho MJ, et al. Phylogenetic analysis reveals a high level of speciation in the Paracoccidioides genus. Mol Phylogenet Evol. 2009;52:273-83.
53. •• Teles FR, Martins ML. Laboratorial diagnosis of paracoccidioidomycosis and new insights for the future of fungal diagnosis. Talanta. 2011;85:2254-64. A comprehensive review on the subject of diagnosis.
54. • Brandt ME, Gómez BL, Warnock D. Histoplasma, Blastomyces, Coccidioides, and other dimorphic fungi causing systemic mycoses. In: Versalovic J, Warnock D, editors. Manual of clinical microbiology. 10th ed. Washington: ASM press; 2011. p. 1902-18. The first in the reading list of articles for non-mycology experienced laboratory personnel.
55. Lindsley MD, Warnock DW, Morrison CJ. Serological and molecular diagnosis of fungal infection. In: Rose NR, Hamilton RG, Detrick B, editors. Manual clinical laboratory immunology. Washington: ASM Press; 2006. p. 569-605.
56. Figueroa JI, Hamilton AJ, Allen MH, et al. Isolation and partial characterization of a Paracoccidioides brasiliensis 58 kDa extracellular glycoprotein which is recognized by human immune sera. Trans R Soc Trop Med Hyg. 1995;89:566-72.
57. Gómez BL, Figueroa JI, Hamilton AJ, et al. Use of monoclonal antibodies in diagnosis of Paracoccidioidomycosis: new strategies for detection of circulating antigens. J Clin Microbiol. 1997;35:3278-83.
58. Ortiz BL, Díez S, Urán ME, et al. Use of the 27-kilodalton recombinant protein from Paracoccidioides brasiliensis in serodiagnosis of paracoccidioidomycosis. Clin Diagn Lab Immunol. 1998;5:826-30.
59. Díez S, Gómez BL, Restrepo A, Hay RJ, et al. Paracoccidioides brasiliensis 87-kilodalton antigen, a heat shock protein useful in diagnosis: characterization, purification, and detection in biopsy material via immunohistochemistry. J Clin Microbiol. 2002;40:359-65.
60. Marques da Silva SH, Colombo AL, Blotta MH, et al. Detection of circulating gp43 antigen in serum, cerebrospinal fluid, and bronchoalveolar lavage fluid of patients with paracoccidioidomycosis. J Clin Microbiol. 2003;41:3675-80.
61. da Silva SH, Grosso Dde M, Lopes JD, et al. Detection of Paracoccidioides brasiliensis gp70 circulating antigen and follow-up of patients undergoing antimycotic therapy. J Clin Microbiol. 2004;42:4480-6.
62. Camargo ZP, Unterkircher C, Travassos LR. Identification of antigenic polypeptides of Paracoccidioides brasiliensis by immunoblotting. J Med Vet Mycol. 1989;27:407-12.
63. Giannini MJ, Bueno JP, Shikanai-Yasuda MA, et al. Antibody response to the 43 kDa glycoprotein of Paracoccidioides brasiliensis as a marker for the evaluation of patients under treatment. AmJTrop Med Hyg. 1990;43:200-6.
64. • Díez S, Gómez BL, McEwen JG, et al. Combined use of Paracoccidioides brasiliensis recombinant 27-kilodalton and purified 87-kilodalton antigens in an enzyme-linked immunosorbent assay for serodiagnosis of paracoccidioidomycosis. J Clin Microbiol. 2003;41:1536-42. More than one recombinant or purified antigen should be used for specific diagnosis.
65. • Buitrago MJ, Merino P, Puente S, et al. Utility of real-time PCR for the detection of Paracoccidioides brasiliensis DNA in the diagnosis of imported paracoccidioidomycosis. Med Mycol. 2009;47:879-82. The door to the use of molecular tests for diagnosis.
66. Motoyama AB, Venancio EJ, Brandão GO, et al. Molecular identification of Paracoccidioides brasiliensis by PCR amplification of ribosomal DNA. J Clin Microbiol. 2000;38:3106-9.
67. Bialek R, Ibricevic A, Aepinus C, et al. Detection of Paracoccidioides brasiliensis in tissue samples by a nested PCR assay. J Clin Microbiol. 2000;38:2940-2.
68. Semighini CP, de Camargo ZP, Puccia R, et al. Molecular identification of Paracoccidioides brasiliensis by 5′ nuclease assay. Diagn Microbiol Infect Dis. 2002;44:383-6.
69. Endo S, Komori T, Ricci G, et al. Detection of gp43 of Paracoccidioides brasiliensis by the loop-mediated isothermal amplification (LAMP) method. FEMS Microbiol Lett. 2004;234(1):93-7.
70. Tatibana BT, Sano A, Uno J, et al. Detection of Paracoccidioides brasiliensis gp43 gene in sputa by loop-mediated isothermal amplification method. J Clin Lab Anal. 2009;23:139-43.
71. • Tobón AM, Agudelo CA, Osorio ML, et al. Residual pulmonary abnormalities in adult patients with chronic paracoccidioidomycosis: prolonged follow-up after itraconazole therapy. Clin Infect Dis. 2003;37:898-904. Be aware of the fibrotic sequela in this mycosis.
72. •• Restrepo A, Benard G, de Castro CC, et al. Pulmonary paracoccidioidomycosis. Semin Respir Crit Care Med. 2008;29:182-97. A comprehensive review to understanding the pivotal role of the lungs in this mycosis.
73. Restrepo A, Tobón A, Agudelo C. Paracoccidioidomycosis. In: Hospenthal DR, Rinaldi MG, editors. Diagnosis and treatment of human mycoses. Totowa: Humana Press; 2008. p. 331-42.
74. • Marchiori E, Valiante PM, Mano CM, et al. Paracoccidioidomycosis: high-resolution computed tomography-pathologic correlation. Eur J Radiol. 2011;77:80-4. Evidence for the large damage caused by the etiologic agent.
75. • Barreto MM, Marchiori E, Amorim VB, et al. Thoracic paracoccidioidomycosis: radiographic and CT findings. RadioGraphics. 2012;32:71-84. A correlation between image techniques that reveals the severity and frequency of the lung damage.
76. Grossklaus Dde A, Tadano T, Breder SA, et al. Acute disseminated paracoccidioidomycosis in a 3 year-old child. Braz J Infect Dis. 2009;13:242-4.
77. Carneiro CR, Miranda BG, Camilo Neto C, et al. Juvenile aracoccidioidomycosis in urban area: report of two cases. Braz J Infect Dis. 2010;14:77-80.
78. Nascimento CR, Delanina WF, Soares CT. Paracoccidioidomycosis: sarcoid-like form in childhood. An Bras Dermatol. 2012;87:486-7.
79. Pereira GH, Santos AQ, Park M, et al. Bone marrow involvement in a patient with paracoccidioidomycosis: a rare presentation of juvenile form. Mycopathologia. 2010;170:259-61.
80. Marques SA, Camargo RM, Abbade LP, et al. Paracoccidioidomycosis: an unusual presentation in a young girl disclosing an unnoted HIV-infection. Med Mycol. 2010;48:182-7.
81. • Rodrigues GS, Severo CB, Oliveira FM, et al. Association between paracoccidioidomycosis and cancer. J Bras Pneumol. 2010;36:356-62. This association is not too frequent but must be taken into consideration.
82. Marques SA, Lastória JC, Marques ME. Paracoccidioidomycosis in a patient with cervical cancer. An Bras Dermatol. 2011;86:587-8.
83. Woyciechowsky TG, Dalcin DC, dos Santos JW, et al. Paracoccidioidomycosis induced by immunosuppressive drugs in a patient with rheumatoid arthritis and bone sarcoma: case report and review of the literature. Mycopathologia. 2011;172:77-81.
84. Goldani LZ. Gastrointestinal paracoccidioidomycosis: an overview. J Clin Gastroenterol. 2011;45:87-91.
85. Araújo SA, Espindola BM, Pedroso ER. Cutaneous disseminated paracoccidioidomycosis. AmJTrop Med Hyg. 2012;86:1.
86. Oñate JM, Tobon AM, Restrepo A. Insuficiencia suprarrenal secundaria a paracoccidioidomicosis. Biomedica. 2002;22:280-6.
87. Tobón AM, Agudelo CA, Restrepo CA, et al. Adrenal function status in patients with paracoccidioidomycosis after prolonged post-therapy follow-up. AmJTrop Med Hyg. 2010;83:111-4.
88. Shikanai-Yasuda MA, Benard G, Higaki Y, et al. Randomized trial with itraconazole, ketoconazole and sulfadiazine in paracoccidioidomycosis. Med Mycol. 2002;40:411-7.
89. •• Shikanai-Yasuda MA, Telles Filho FQ, Mendes RP, et al. Guidelines in paracoccidioidomycosis. Rev Soc Bras Med Trop. 2006;39:297-310. A classic in treatment approaches.
90. Queiros-Tellez F, Goldani LZ, Schamm HT, et al. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. Clin Infect Dis. 2007;45:1462-9.
91. Benard G, Campos AF, Netto LC, et al. Treatment of severe forms of paracoccidioidomycosis: is there a role for corticosteroids? Med Mycol. 2012;50:641-8.